Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chalazion × tyramine-deoxysorbitol × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

tyramine-deoxysorbitol 1 Triamcinolone Acetonide 1 Triamcinolone 1 Fluorouracil 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03248440 2021-08-05

SUNRISE

Senju USA, Inc.

Phase 3 Completed

263 enrolled 7 charts

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡